It is shown that splice-switching ASOs can elicit target exon skipping and up-regulate endogenous protein levels, and it is shown that TSC1 uORFs act additively to reduce protein translation.
Abstract
Rare genetic disorders collectively impact over 300 million people worldwide, yet around 95% have no specific treatments. For the many rare disorders caused by haploinsufficiency, effective therapies need to upregulate protein expression. However, therapeutic upregulation is often not straightforward. Increasing protein translation from the wildtype allele through inhibiting repressive upstream open reading frames (uORFs) has been proposed as a therapeutic approach for a few specific genes. The widespread success of steric-block antisense oligonucleotides (ASOs) for this purpose is, however, debated.
Here, we explore an alternative approach, using splice-switching to exclude uORF-containing exons from the mRNA. We defined 2,210 potentially ‘skippable’ 5ʹUTR exons using MANE transcript definitions. uORF start codons in these exons were identified using ribosome profiling data from 13 human tissues and cell lines, including brain, heart and skeletal muscle. The effect of skipping six prioritised candidate target exons on downstream translation was assessed using dual luciferase assays.
We identified 1,056 skippable 5ʹUTR exons containing uORF start codons, 79 of which were in haploinsufficient monogenic disease genes. We prioritised six candidate 5ʹUTR exons in neurodevelopmental disorder genes and demonstrate that removing the target exon significantly increased protein translation (between 1.4 to 5.5-fold) for four of the six prioritised genes (
CTCF
,
GRIN2B
,
KRIT1
, and
TSC1
). Further, we show that this effect is likely primarily driven by the uORF rather than other regulatory factors within the target exons, as removing the uORF start sites alone increased protein translation to comparative levels (between 1.4 to 7.9-fold). For a single gene target (
TSC1
), we show that splice-switching ASOs can elicit target exon skipping and up-regulate endogenous protein levels. Further, we show that
TSC1
uORFs act additively to reduce protein translation.
We show that skipping 5ʹUTR exons can boost protein translation. This supports the broad application of 5ʹUTR exon skipping as a therapeutic mechanism to upregulate protein production from clinically relevant haploinsufficient genes.
BACKGROUND: Disruption of MYBPC3 precursor mRNA splicing is a frequent genetic cause of hypertrophic cardiomyopathy (HCM). Most often, it reflects changes at canonical sites or the creation of novel splice sites. Prediction tools usually prioritize splice variants with lower efficiency when they are distant from canoni...
M. Gallego-Delgado, S. L. Lorenzo Hernández, Soledad García Hernández et al.· Circulation· 0 citations
This gene-agnostic framework establishes a systematic strategy for identifying intronic mutational hotspots and matching patients to scalable, mutation-agnostic ASO-based precision therapies.
H. Saei, B. Ardin, N. Kaiser et al.· medRxiv· 0 citations
By leveraging specialized approaches for prioritizing pseudogenes, combined with the PCG and snRNA analysis, the genes and variants expand the variant pathogenicity spectrum of spliceosomopathies and suggest variants for follow-up case series and future functional validation.
O. Messaoud, S. DiTroia, R. Tarawneh et al.· medRxiv· 0 citations
A generalizable framework to modulate gene dosage by alternative splicing via genome editing is presented, allowing high-fidelity animal models for human diseases caused by haploinsufficiency and leaving endogenous gene expression regulatory logic intact.
Eric D. Smith, Joshua K. Meisner, Abbey Bullard et al.· bioRxiv· 0 citations
A streamlined minigene-based workflow for rapid functional evaluation of splicing variants and a robust and scalable framework for functional interpretation of splicing variants is developed, improving diagnostic resolution and supporting more informed clinical decision-making in hereditary cancer genetics.
Noemi Calandra, Elisabetta Mereu, P. Ogliara et al.· Journal of Medical Genetics· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.